MP58-04 A RANDOMIZED DOUBLE BLINDED PLACEBO CONTROLLED CROSSOVER PILOT TRIAL BETWEEN ANASTROZOLE AND CLOMIPHENE TO EVALUATE IMPROVEMENT IN HYPOGONADAL SYMPTOMS AND ERECTILE FUNCTION
2019
INTRODUCTION AND OBJECTIVES:The use of selective estrogen receptor modifiers (SERM) and aromatase inhibitors (AI) have been used for decades for the treatment of secondary hypogonadism. While both ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI